ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Summit Conference Reviews Leads In Leukemia, Lymphoma

January 8, 1982

ASCO Honors Holland, Koop, Monaco With Special Awards

June 11, 1993

Smoking/Health Program Seeks Grants; Ideas For RFAs RFPs Being Considered

December 5, 1980

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002